- Home
- PYPD vs AWH Comparison
PYPD vs AWH Comparison
Compare PYPD & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- AWH
- Stock Information
- Founded
- PYPD 2008
- AWH 1993
- Country
- PYPD Israel
- AWH United States
- Employees
- PYPD N/A
- AWH N/A
- Industry
- PYPD Medical/Dental Instruments
- AWH Medical/Dental Instruments
- Sector
- PYPD Health Care
- AWH Health Care
- Exchange
- PYPD Nasdaq
- AWH Nasdaq
- Market Cap
- PYPD 16.3M
- AWH 13.5M
- IPO Year
- PYPD 2020
- AWH N/A
- Fundamental
- Price
- PYPD $3.54
- AWH $0.80
- Analyst Decision
- PYPD Buy
- AWH Buy
- Analyst Count
- PYPD 2
- AWH 2
- Target Price
- PYPD $12.00
- AWH $4.40
- AVG Volume (30 Days)
- PYPD 4.6K
- AWH 68.8K
- Earning Date
- PYPD 11-06-2024
- AWH 11-11-2024
- Dividend Yield
- PYPD N/A
- AWH N/A
- EPS Growth
- PYPD N/A
- AWH N/A
- EPS
- PYPD N/A
- AWH N/A
- Revenue
- PYPD N/A
- AWH $8,923,000.00
- Revenue This Year
- PYPD N/A
- AWH $15.59
- Revenue Next Year
- PYPD N/A
- AWH $108.47
- P/E Ratio
- PYPD N/A
- AWH N/A
- Revenue Growth
- PYPD N/A
- AWH N/A
- 52 Week Low
- PYPD $2.95
- AWH $0.74
- 52 Week High
- PYPD $9.20
- AWH $6.01
- Technical
- Relative Strength Index (RSI)
- PYPD 50.82
- AWH 41.90
- Support Level
- PYPD $3.31
- AWH $0.74
- Resistance Level
- PYPD $3.75
- AWH $0.89
- Average True Range (ATR)
- PYPD 0.19
- AWH 0.06
- MACD
- PYPD 0.01
- AWH 0.02
- Stochastic Oscillator
- PYPD 51.22
- AWH 56.11
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.